Synthesis of New Hydrazone Derivatives and Evaluation of their Efficacy as Proliferation Inhibitors in Human Cancer Cells

(E-pub Ahead of Print)

Author(s): Piotr Świątek* , Jolanta Saczko , Nina Rembiałkowska , Julita Kulbacka .

Journal Name: Medicinal Chemistry

Become EABM
Become Reviewer


Background: Hydrazine-hydrazones represent a group of bioactive compounds that display antibacterial, anti-inflammatory, antiviral or anticancer activities.

Objective: In this study, we designed new derivative compounds from groups of hydrazones.

Method: The group of new derivatives was evaluated by the viability assay in human cancer and normal cells.

Results: The dimethylpyridine hydrazones showed potent inhibition of cell proliferation of breast, colon cancer cells, human melanoma and glioblastoma. Compound 12 inhibited proliferation of cancer cells exhibiting a drug-resistant phenotype (MCF-7/DX and LoVoDX) at low millimolar concentrations. Whereas, antimelanoma activity was revealed by Compounds 2, 4, 7 and 12.

Conclusion: The present results highlighted newly synthetized hydrazine derivatives an excellent base for the design of new anticancer agents and resistance inhibitors.

Keywords: hydrazones, cancer cells, proliferation inhibitor, anticancer, synthesis, MTT

Rights & PermissionsPrintExport Cite as

Article Details

(E-pub Ahead of Print)
DOI: 10.2174/1573406415666190128100524
Price: $95